ESC Professional Premium Access

Inactivation of catalytic and non-catalytic PI3 kinase gamma functions enhances hypoxia-induced pulmonary hypertension in mice

Congress Presentation

About the speaker

Mrs Leoni Gnatzy-Feik

Heart Center at the University of Cologne, Cologne (Germany)
0 follower

4 more presentations in this session

The efficacy and safety of macitentan in Fontan-palliated patients: results of the 52-week randomised, placebo-controlled RUBATO trial

Speaker: Doctor P. Clift (Birmingham, GB)

Thumbnail

Ventricular-arterial coupling predicts outcomes in adults with a systemic right ventricle

Speaker: Doctor G. Pasqualin (Milan, IT)

Thumbnail

Investigating monotherapy and combination therapy trends in newly diagnosed patients with pulmonary arterial hypertension among EU3 & UK physicians over the COVID-19 pandemic.

Speaker: Mr D. Chandler (London, GB)

Thumbnail

Efficacy and safety of selexipag in real-life in patients with pulmonary arterial hypertension: early results of RAMPHA study

Speaker: Doctor R. Bravo-Marques (Marbella, ES)

Thumbnail

Access the full session

Focus on the pulmonary vascular bed

Speakers: Mrs L. Gnatzy-Feik, Doctor P. Clift, Doctor G. Pasqualin, Mr D. Chandler, Doctor R. Bravo-Marques
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb